European Heart Journal最新文献

筛选
英文 中文
Deep learning for cardiac abnormalities in chest X-rays: performance metrics with imbalanced data and extracardiac objects. 胸部x射线中心脏异常的深度学习:数据不平衡和心外物体的性能指标。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-08 DOI: 10.1093/eurheartj/ehae759
Eisuke Kagawa, Masaya Kato, Keigo Dote
{"title":"Deep learning for cardiac abnormalities in chest X-rays: performance metrics with imbalanced data and extracardiac objects.","authors":"Eisuke Kagawa, Masaya Kato, Keigo Dote","doi":"10.1093/eurheartj/ehae759","DOIUrl":"https://doi.org/10.1093/eurheartj/ehae759","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":""},"PeriodicalIF":37.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myxoedema coma and myxoedema heart disease. 黏液水肿昏迷和黏液水肿心脏病。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-08 DOI: 10.1093/eurheartj/ehae937
Philip Haaf, Julia Beck, Michael Mayr
{"title":"Myxoedema coma and myxoedema heart disease.","authors":"Philip Haaf, Julia Beck, Michael Mayr","doi":"10.1093/eurheartj/ehae937","DOIUrl":"https://doi.org/10.1093/eurheartj/ehae937","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":""},"PeriodicalIF":37.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart). 心血管疾病临床研究结果测量的定义:欧洲心脏护理评估和随机试验统一登记处(EuroHeart)。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-07 DOI: 10.1093/eurheartj/ehae724
Chris Wilkinson, Asad Bhatty, Gorav Batra, Suleman Aktaa, Adam B Smith, Jeremy Dwight, Marcin Ruciński, Sam Chappell, Joakim Alfredsson, David Erlinge, Jorge Ferreira, Ingibjörg J Guðmundsdóttir, Þórdís Jóna Hrafnkelsdóttir, Inga Jóna Ingimarsdóttir, Alar Irs, András Jánosi, Zoltán Járai, Manuel Oliveira-Santos, Bogdan A Popescu, Peter Vasko, Dragos Vinereanu, Jonathan Yap, Raffaele Bugiardini, Edina Cenko, Ramesh Nadarajah, Matthew R Sydes, Stefan James, Aldo P Maggioni, Lars Wallentin, Barbara Casadei, Chris P Gale
{"title":"Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).","authors":"Chris Wilkinson, Asad Bhatty, Gorav Batra, Suleman Aktaa, Adam B Smith, Jeremy Dwight, Marcin Ruciński, Sam Chappell, Joakim Alfredsson, David Erlinge, Jorge Ferreira, Ingibjörg J Guðmundsdóttir, Þórdís Jóna Hrafnkelsdóttir, Inga Jóna Ingimarsdóttir, Alar Irs, András Jánosi, Zoltán Járai, Manuel Oliveira-Santos, Bogdan A Popescu, Peter Vasko, Dragos Vinereanu, Jonathan Yap, Raffaele Bugiardini, Edina Cenko, Ramesh Nadarajah, Matthew R Sydes, Stefan James, Aldo P Maggioni, Lars Wallentin, Barbara Casadei, Chris P Gale","doi":"10.1093/eurheartj/ehae724","DOIUrl":"10.1093/eurheartj/ehae724","url":null,"abstract":"<p><strong>Background and aims: </strong>Standardized definitions for outcome measures in randomized clinical trials and observational studies are essential for robust and valid evaluation of medical products, interventions, care, and outcomes. The European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) project of the European Society of Cardiology aimed to create international data standards for cardiovascular clinical study outcome measures.</p><p><strong>Methods: </strong>The EuroHeart methods for data standard development were used. From a Global Cardiovascular Outcomes Consortium of 82 experts, five Working Groups were formed to identify and define key outcome measures for: cardiovascular disease (generic outcomes), acute coronary syndrome and percutaneous coronary intervention (ACS/PCI), atrial fibrillation (AF), heart failure (HF) and transcatheter aortic valve implantation (TAVI). A systematic review of the literature informed a modified Delphi method to reach consensus on a final set of variables. For each variable, the Working Group provided a definition and categorized the variable as mandatory (Level 1) or optional (Level 2) based on its clinical importance and feasibility.</p><p><strong>Results: </strong>Across the five domains, 24 Level 1 (generic: 5, ACS/PCI: 8, AF: 2; HF: 5, TAVI: 4) and 48 Level 2 (generic: 18, ACS-PCI: 7, AF: 6, HF: 2, TAVI: 15) outcome measures were defined.</p><p><strong>Conclusions: </strong>Internationally derived and endorsed definitions for outcome measures for a range of common cardiovascular diseases and interventions are presented. These may be used for data alignment to enable high-quality observational and randomized clinical research, audit, and quality improvement for patient benefit.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"190-214"},"PeriodicalIF":37.6,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Device-measured physical activity and cardiac structure by magnetic resonance. 通过磁共振设备测量体力活动和心脏结构。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-07 DOI: 10.1093/eurheartj/ehae506
Thomas Yates, Cameron Razieh, Joe Henson, Alex V Rowlands, Jonathan Goldney, Gaurav S Gulsin, Melanie J Davies, Kamlesh Khunti, Francesco Zaccardi, Gerry P McCann
{"title":"Device-measured physical activity and cardiac structure by magnetic resonance.","authors":"Thomas Yates, Cameron Razieh, Joe Henson, Alex V Rowlands, Jonathan Goldney, Gaurav S Gulsin, Melanie J Davies, Kamlesh Khunti, Francesco Zaccardi, Gerry P McCann","doi":"10.1093/eurheartj/ehae506","DOIUrl":"10.1093/eurheartj/ehae506","url":null,"abstract":"<p><strong>Background and aims: </strong>Although extreme cardiac adaptions mirroring phenotypes of cardiomyopathy have been observed in endurance athletes, adaptions to high levels of physical activity within the wider population are under-explored. Therefore, in this study, associations between device-measured physical activity and clinically relevant cardiac magnetic resonance volumetric indices were investigated.</p><p><strong>Methods: </strong>Individuals without known cardiovascular disease or hypertension were included from the UK Biobank. Cardiac magnetic resonance data were collected between 2015 and 2019, and measures of end-diastolic chamber volume, left ventricular (LV) wall thickness, and LV ejection fraction were extracted. Moderate-to-vigorous-intensity physical activity (MVPA), vigorous-intensity physical activity (VPA), and total physical activity were assessed via wrist-worn accelerometers.</p><p><strong>Results: </strong>A total of 5977 women (median age and MVPA: 62 years and 46.8 min/day, respectively) and 4134 men (64 years and 49.8 min/day, respectively) were included. Each additional 10 min/day of MVPA was associated with a 0.70 [95% confidence interval (CI): 0.62, 0.79] mL/m2 higher indexed LV end-diastolic volume (LVEDVi) in women and a 1.08 (95% CI: 0.95, 1.20) mL/m2 higher LVEDVi in men. However, even within the top decile of MVPA, LVEDVi values remained within the normal ranges [79.1 (95% CI: 78.3, 80.0) mL/m2 in women and 91.4 (95% CI: 90.1, 92.7) mL/m2 in men]. Associations with MVPA were also observed for the right ventricle and the left/right atria, with an inverse association observed for LV ejection fraction. Associations of MVPA with maximum or average LV wall thickness were not clinically meaningful. Results for total physical activity and VPA mirrored those for MVPA.</p><p><strong>Conclusions: </strong>High levels of device-measured physical activity were associated with cardiac remodelling within normal ranges.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"176-186"},"PeriodicalIF":37.6,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial. 基于声学的稳定型冠状动脉疾病排除:FILTER-SCAD 试验。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-07 DOI: 10.1093/eurheartj/ehae570
Louise Hougesen Bjerking, Kim Wadt Skak-Hansen, Merete Heitmann, Jens Dahlgaard Hove, Sune Ammentorp Haahr-Pedersen, Henrik Engblom, David Erlinge, Sune Bernd Emil Werner Räder, Jens Brønnum-Schou, Tor Biering-Sørensen, Camilla Lyngby Kjærgaard, Søren Strange, Søren Galatius, Eva Irene Bossano Prescott
{"title":"Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial.","authors":"Louise Hougesen Bjerking, Kim Wadt Skak-Hansen, Merete Heitmann, Jens Dahlgaard Hove, Sune Ammentorp Haahr-Pedersen, Henrik Engblom, David Erlinge, Sune Bernd Emil Werner Räder, Jens Brønnum-Schou, Tor Biering-Sørensen, Camilla Lyngby Kjærgaard, Søren Strange, Søren Galatius, Eva Irene Bossano Prescott","doi":"10.1093/eurheartj/ehae570","DOIUrl":"10.1093/eurheartj/ehae570","url":null,"abstract":"<p><strong>Background and aims: </strong>Overtesting of low-risk patients with suspect chronic coronary syndrome (CCS) is widespread. The acoustic-based coronary artery disease (CAD)-score has superior rule-out capabilities when added to pre-test probability (PTP). FILTER-SCAD tested whether providing a CAD-score and PTP to cardiologists was superior to PTP alone in limiting testing.</p><p><strong>Methods: </strong>At six Danish and Swedish outpatient clinics, patients with suspected new-onset CCS were randomized to either standard diagnostic examination (SDE) with PTP, or SDE plus CAD-score, and cardiologists provided with corresponding recommended diagnostic flowcharts. The primary endpoint was cumulative number of diagnostic tests at one year and key safety endpoint major adverse cardiac events (MACE).</p><p><strong>Results: </strong>In total, 2008 patients (46% male, median age 63 years) were randomized from October 2019 to September 2022. When randomized to CAD-score (n = 1002), it was successfully measured in 94.5%. Overall, 13.5% had PTP ≤ 5%, and 39.5% had CAD-score ≤ 20. Testing was deferred in 22% with no differences in diagnostic tests between groups (P for superiority = .56). In the PTP ≤ 5% subgroup, the proportion with deferred testing increased from 28% to 52% (P < .001). Overall MACE was 2.4 per 100 person-years. Non-inferiority regarding safety was established, absolute risk difference 0.49% (95% confidence interval -1.96-0.97) (P for non-inferiority = .003). No differences were seen in angina-related health status or quality of life.</p><p><strong>Conclusions: </strong>The implementation strategy of providing cardiologists with a CAD-score alongside SDE did not reduce testing overall but indicated a possible role in patients with low CCS likelihood. Further strategies are warranted to address resistance to modifying diagnostic pathways in this patient population.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"117-128"},"PeriodicalIF":37.6,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142105719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atrial fibrillation ablation timing: where is the sweet spot? 心房颤动消融时机:最佳时机在哪里?
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-03 DOI: 10.1093/eurheartj/ehae892
Jonathan M Kalman, Peter M Kistler, Gerhard Hindricks, Prashanthan Sanders
{"title":"Atrial fibrillation ablation timing: where is the sweet spot?","authors":"Jonathan M Kalman, Peter M Kistler, Gerhard Hindricks, Prashanthan Sanders","doi":"10.1093/eurheartj/ehae892","DOIUrl":"https://doi.org/10.1093/eurheartj/ehae892","url":null,"abstract":"<p><p>Convincing evidence for the efficacy of ablation as first-line therapy in paroxysmal AF (PAF) and its clear superiority to medical therapy for rhythm control in both PAF and persistent AF (PsAF) has generated considerable interest in the optimal timing of ablation. Based on this data, there is a widespread view that the principle of 'the earlier the better' should be generally applied. However, the natural history of AF is highly variable and non-linear, and for this reason, it is difficult to be emphatic that all patients are best served by ablation early after their initial AF episodes. Sufficient evidence exists to indicate a conservative approach is reasonable in patients with infrequent and non-progressive episodes (i.e. absence of progressive increase in burden culminating in PsAF) in whom symptoms remain mild and well-controlled. A conservative management phase should be marked by assiduous attention to risk factor modification, changes in frequency and duration of AF episodes, and patient preferences. If and when AF does begin to progress, accumulating evidence indicates that early ablation accompanied by ongoing attention to risk factors provides the best outcomes.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":""},"PeriodicalIF":37.6,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
24-hour ambulatory blood pressure monitoring: a game changer in the management of reflex syncope? 24小时动态血压监测:反射性晕厥治疗的改变者?
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-03 DOI: 10.1093/eurheartj/ehae872
Peter Mitro
{"title":"24-hour ambulatory blood pressure monitoring: a game changer in the management of reflex syncope?","authors":"Peter Mitro","doi":"10.1093/eurheartj/ehae872","DOIUrl":"https://doi.org/10.1093/eurheartj/ehae872","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":""},"PeriodicalIF":37.6,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weekly Journal Scan: FINEARTS-HF supports the role of aldosterone antagonism in the management of heart failure with mildly reduced or preserved ejection fraction. 每周期刊扫描:FINEARTS-HF 支持醛固酮拮抗剂在治疗射血分数轻度降低或保留的心力衰竭中的作用。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-03 DOI: 10.1093/eurheartj/ehae679
Massimo Volpe, Leonarda Galiuto
{"title":"Weekly Journal Scan: FINEARTS-HF supports the role of aldosterone antagonism in the management of heart failure with mildly reduced or preserved ejection fraction.","authors":"Massimo Volpe, Leonarda Galiuto","doi":"10.1093/eurheartj/ehae679","DOIUrl":"10.1093/eurheartj/ehae679","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"103-104"},"PeriodicalIF":37.6,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gold standard: Karin Sipido honoured for pioneering work. 黄金标准:卡琳-西皮多(Karin Sipido)因开创性工作而获奖。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-03 DOI: 10.1093/eurheartj/ehae741
Judith Ozkan
{"title":"Gold standard: Karin Sipido honoured for pioneering work.","authors":"Judith Ozkan","doi":"10.1093/eurheartj/ehae741","DOIUrl":"10.1093/eurheartj/ehae741","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"15-16"},"PeriodicalIF":37.6,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging. 瓣膜性心脏病术前使用非维生素 K 口服抗凝剂:桥接与不桥接的故事。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-01-03 DOI: 10.1093/eurheartj/ehae615
Raffaele De Caterina, Hugo Ten Cate, Vittorio Pengo
{"title":"Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging.","authors":"Raffaele De Caterina, Hugo Ten Cate, Vittorio Pengo","doi":"10.1093/eurheartj/ehae615","DOIUrl":"10.1093/eurheartj/ehae615","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"35-37"},"PeriodicalIF":37.6,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142389076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信